JPMorgan Chase Reduces Stake in Exponent, Inc.

Institutional investor trims position in engineering and consulting firm

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

JPMorgan Chase & Co. has reduced its stake in Exponent, Inc. (NASDAQ: EXPO) by 24.7% during the third quarter, according to a recent SEC filing. The financial services giant now owns 480,624 shares of the business services provider, valued at $33.39 million.

Why it matters

This move by a major institutional investor like JPMorgan Chase provides insight into market sentiment around Exponent, a leading engineering and scientific consulting firm. The reduction in stake could signal broader investor concerns or a shift in portfolio strategy.

The details

According to the SEC filing, JPMorgan Chase sold 157,457 shares of Exponent during the third quarter, reducing its total position to 480,624 shares. The firm now owns approximately 0.95% of Exponent's outstanding stock. Exponent provides a range of analysis and advisory services to clients across various industries, including product design, performance evaluation, litigation consulting, and regulatory compliance.

  • JPMorgan Chase reduced its Exponent stake during the 3rd quarter of 2026.

The players

JPMorgan Chase & Co.

A major American multinational investment bank and financial services company.

Exponent, Inc.

An engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries.

Got photos? Submit your photos here. ›

The takeaway

The reduction in JPMorgan Chase's Exponent stake suggests potential investor concerns about the engineering consulting firm's outlook, though the overall market sentiment remains moderately positive with a 'Moderate Buy' consensus rating from analysts.